Samantha Tabone is a partner at Empath Ventures where she leads in-depth technical and scientific due diligence on Empath’s psychedelic biotech investments.
Sam served as the VP of R&D for PurMinds, a neuromedicine startup developing novel therapeutics for neurodegenerative diseases. As an independent consultant she’s led projects for leading psychedelic companies including Beckley Psytech, advised family offices on Life Science investment strategies, and worked as a temporary strategic director at several biotech startups.
Sam has been fascinated with neuroscience and psychedelics (especially DMT) since she was in her teens. She’s most excited about funding psychedelic startups working towards solutions for complex neurological disorders.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.